Qube Research & Technologies (QRT) Portfolio holdings
AUM $72B
1-Year Return
7.86%
This Quarter Return
-0.96%
1 Year Return
+7.86%
3 Year Return
+23.62%
5 Year Return
+38.38%
10 Year Return
–
AUM
$54.2B
AUM Growth
-$1.16B
(-2.1%)
Cap. Flow
-$432M
Cap. Flow
% of AUM
-0.8%
Top 10 Holdings %
Top 10 Hldgs %
16.28%
Holding
4,400
New
506
Increased
1,215
Reduced
1,314
Closed
1,050
Top Buys
| 1 |
Broadcom
AVGO
|
+$643M |
| 2 |
Accenture
ACN
|
+$430M |
| 3 |
Merck
MRK
|
+$363M |
| 4 |
Lam Research
LRCX
|
+$324M |
| 5 |
Northrop Grumman
NOC
|
+$323M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$537M |
| 2 |
Zoetis
ZTS
|
+$359M |
| 3 |
UnitedHealth
UNH
|
+$347M |
| 4 |
McDonald's
MCD
|
+$330M |
| 5 |
Honeywell
HON
|
+$292M |
Sector Composition
| 1 | Technology | 20.91% |
| 2 | Industrials | 13.11% |
| 3 | Financials | 11.91% |
| 4 | Healthcare | 11.89% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Oaktree Specialty Lending
OCSL
$1.17B
| $302K | ﹤0.01% |
+16,080
| New | +$302K |
|
1977
Adicet Bio
ACET
$67.6M
| $302K | ﹤0.01% |
249,357
+140,116
| +128% | +$170K |
|
1978
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$658M
| $299K | ﹤0.01% |
+2,639
| New | +$299K |
|
1979
Spyre Therapeutics
SYRE
$909M
| $298K | ﹤0.01% |
12,672
-45,006
| -78% | -$1.06M |
|
1980
McEwen Inc.
MUX
$730M
| $298K | ﹤0.01% |
+32,448
| New | +$298K |
|
1981
Lifeway Foods
LWAY
$510M
| $298K | ﹤0.01% |
23,317
+7,975
| +52% | +$102K |
|
|
CTEV
1982
Claritev Corporation
CTEV
$940M
| $297K | ﹤0.01% |
19,137
+16,404
| +600% | +$255K |
|
1983
Vanguard Mega Cap Growth ETF
MGK
$30.3B
| $297K | ﹤0.01% |
946
+869
| +1,129% | +$273K |
|
1984
Telus
TU
$24.3B
| $296K | ﹤0.01% |
19,583
-257,136
| -93% | -$3.89M |
|
1985
The Joint Corp
JYNT
$153M
| $296K | ﹤0.01% |
+21,038
| New | +$296K |
|
1986
Global X Artificial Intelligence & Technology ETF
AIQ
$5.02B
| $296K | ﹤0.01% |
+8,298
| New | +$296K |
|
1987
Innoviva
INVA
$1.22B
| $294K | ﹤0.01% |
17,901
-27,185
| -60% | -$446K |
|
1988
Excelerate Energy
EE
$761M
| $292K | ﹤0.01% |
15,862
+8,723
| +122% | +$161K |
|
1989
Carpenter Technology
CRS
$12.2B
| $292K | ﹤0.01% |
2,663
-86,901
| -97% | -$9.52M |
|
1990
Marqeta
MQ
$2.6B
| $290K | ﹤0.01% |
52,995
-615,869
| -92% | -$3.37M |
|
1991
Dianthus Therapeutics
DNTH
$1.49B
| $290K | ﹤0.01% |
11,205
-56,641
| -83% | -$1.47M |
|
1992
Cambria Shareholder Yield ETF
SYLD
$931M
| $289K | ﹤0.01% |
4,235
-3,342
| -44% | -$228K |
|
1993
iShares Preferred and Income Securities ETF
PFF
$14.8B
| $289K | ﹤0.01% |
+9,149
| New | +$289K |
|
1994
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$14.5B
| $288K | ﹤0.01% |
2,695
-1,406
| -34% | -$150K |
|
1995
Greenlight Captial
GLRE
$429M
| $288K | ﹤0.01% |
21,979
-1,929
| -8% | -$25.3K |
|
1996
BP
BP
$88.3B
| $287K | ﹤0.01% |
7,961
-1,934,535
| -100% | -$69.8M |
|
1997
Fennec Pharmaceuticals
FENC
$241M
| $287K | ﹤0.01% |
46,984
+38,100
| +429% | +$233K |
|
1998
The RMR Group
RMR
$292M
| $287K | ﹤0.01% |
12,694
+10,885
| +602% | +$246K |
|
1999
iShares Core S&P US Growth ETF
IUSG
$25.3B
| $286K | ﹤0.01% |
2,243
+1,427
| +175% | +$182K |
|
2000
Intercorp Financial Services
IFS
$4.63B
| $285K | ﹤0.01% |
12,703
-8,573
| -40% | -$192K |
|